MoneyWorks4Me

Kopran - Quaterly Results

03 Feb 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 545.73 millions against Rs. 565.62 millions recorded during the year-ago period.Net Profit of the company move down -46.29% to Rs. 23.23  millions from Rs. 43.25 millions  in the same quarter last year.A decline of 50.34 millions was observed in the OP in the quarter ended December 2021 from 78.15 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 545.73 565.62 -3.52 1400.18 1608.68 -12.96 2228.33 1792.91 24.29
Other Income 15.80 25.23 -37.38 59.03 81.82 -27.85 104.14 19.90 423.32
PBIDT 50.34 78.15 -35.59 144.79 313.24 -53.78 406.14 251.66 61.38
Interest 9.75 6.98 39.68 21.56 32.70 -34.07 38.07 59.62 -36.15
PBDT 40.59 71.17 -42.97 123.23 280.54 -56.07 368.07 192.04 91.66
Depreciation 10.98 10.51 4.47 32.63 30.56 6.77 41.03 34.72 18.17
PBT 29.61 60.66 -51.19 90.60 249.98 -63.76 327.04 157.32 107.88
TAX 6.38 17.41 -63.35 20.90 71.65 -70.83 92.33 45.13 104.59
Deferred Tax 1.31 6.64 -80.27 5.07 27.91 -81.83 34.76 17.12 103.04
PAT 23.23 43.25 -46.29 69.70 178.33 -60.92 234.71 112.19 109.21
Equity 432.52 432.49 0.01 432.52 432.49 0.01 432.52 432.49 0.01
PBIDTM(%) 9.22 13.82 -33.24 10.34 19.47 -46.89 18.23 14.04 29.85
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..